Foszfolipidellenes antitestek akut coronaria szindrómában.

Translated title of the contribution: Antiphospholipid antibodies in acute coronary syndrome

Pál Soltész, Katalin Veres, Gabriella Lakos, Adrienn Kerényi, Gyula Szegedi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The authors examined the presence of antiphospholipid antibodies in acute coronary syndrome. As their results show the frequency of antibodies against B2-glycoprotein I is significantly higher (14.4%) than the presence of these antibodies in a healthy control group (2%). Occurrence of antibodies against B2-glycoprotein I is much more higher than the occurrence of IgG- or IgM type antibodies against cardiolipin or lupus anticoagulant. CONCLUSIONS: The authors emphasize the possible role of anti-B2-glycoprotein I antibodies in thrombotic process of acute coronary syndrome. The previous ischaemic stroke was significantly more frequent in those patients medical history in whose serums antibodies against B2-glycoprotein I were present, so the presence of this thrombophil factor in acute coronary syndrome points out the importance of secunder antithrombotic prevention.

Translated title of the contributionAntiphospholipid antibodies in acute coronary syndrome
Original languageHungarian
Pages (from-to)461-466
Number of pages6
JournalOrvosi hetilap
Volume144
Issue number10
Publication statusPublished - Mar 9 2003

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Antiphospholipid antibodies in acute coronary syndrome'. Together they form a unique fingerprint.

  • Cite this